Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference29 articles.
1. Alternatives to lobectomy for high-risk patients with early-stage non-small cell lung cancer;Klapper;Ann Thorac Surg,2017
2. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer;Timmerman;J Clin Oncol,2006
3. OA24.05 The Nordic HILUS-Trial – first report of a phase II trial of SBRT of centrally located lung tumors;Lindberg;J Thoracic Oncol,2017
4. Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, et al., Efficacy and toxicity analysis of NRG oncology/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 96, S8.
5. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree;Haseltine;Pract Radiat Oncol,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Patients With Non-Small Cell Lung Cancer Receiving Lung Radiation Therapy and Immunotherapy;International Journal of Radiation Oncology*Biology*Physics;2023-11
2. Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus;International Journal of Radiation Oncology*Biology*Physics;2021-12
3. Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?;International Journal of Radiation Oncology*Biology*Physics;2021-05
4. Improving geometric sparing and therapeutic effectiveness of lung SBRT for central and ultra-central tumors;Medical Dosimetry;2021
5. Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy;Strahlentherapie und Onkologie;2020-09-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3